| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |